Project Details
Projekt Print View

Novel functions of Retinol Saturase in glucose sensing

Subject Area Endocrinology, Diabetology, Metabolism
Pharmacology
Cell Biology
Term from 2018 to 2025
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 415542650
 
Final Report Year 2025

Final Report Abstract

Retinol Saturase (RetSat) is an oxidoreductase localized in the endoplasmic reticulum and highly expressed in metabolically active organs like liver, intestine, and adipose tissue. Although initially implicated in the synthesis of 13,14-dihydroretinol, RetSat likely convers other yet unknown enzymatic reactions. This project analyzed tissue-specific functions of RetSat in novel genetic mouse models and human tissue samples. We found that RetSat expression is under β-adrenergic control in adipocytes and determines thermogenic capacity of brown adipocytes and acute cold tolerance in mice. RetSat expression in subcutaneous white adipose tissue of humans correlates with the expression of genes related to mitochondrial function. In regard to the underlying mechanism, we found that RetSat depletion in adipocytes impaired βagonist-induced lipolysis, which represents a major determinant of thermogenic gene expression in these cells. In the intestine, RetSat localizes to intestinal epithelial cells and its deletion decreased weight gain and fat mass in obese mice. In colitis, which downregulated intestinal RetSat expression in humans and mice, RetSat ablation improved the epithelial architecture of the murine colon, potentially by reducing the production of reactive oxygen species. Finally, we found that a hepatocyte-specific RetSat deletion in mice did not alter the concentration of retinol and 13,14-dihydroretinol in liver tissue, suggesting that its enzymatic activity and cellular functions are independent of vitamin A. These insights will help to develop RetSat as novel pharmacologic target for metabolic diseases.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung